Immunometabolic signatures predict risk of progression to sepsis in COVID-19

Ana Sofía Herrera-Van Oostdam(Autonomous University of San Luis Potosí), Yamilé López‐Hernández(The Metabolomics Innovation Centre), Juan Carlos Borrego(Mexican Social Security Institute), Julio C. Fernández-Ruiz(Mexican Social Security Institute), Jesús Adrián López(Universidad Autónoma de Zacatecas "Francisco García Salinas"), Joel Monárrez‐Espino(Autonomous University of Chihuahua), Juan José Oropeza-Valdez(National Institute of Genomic Medicine), José Antonio Enciso‐Moreno(Mexican Social Security Institute), Elizabeth Soto-Guzmán(Universidad Autónoma de Zacatecas "Francisco García Salinas"), Flor María Trejo Medinilla(Universidad Autónoma de Zacatecas "Francisco García Salinas"), Julio Enrique Castañeda‐Delgado(Universidad Politécnica de Zacatecas), Lun Zhang(National University of Defense Technology), Jiamin Zheng(University of Alberta), David S. Wishart(University of Alberta), Rupasri Mandal(University of Alberta), Fátima de Lourdes Ochoa-González(Mexican Social Security Institute)
PLoS ONE
August 30, 2021
Cited by 49


Related Papers